- Home
- INOD vs ARQT Comparison
INOD vs ARQT Comparison
Compare INOD & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- ARQT
- Stock Information
- Founded
- INOD 1988
- ARQT 2016
- Country
- INOD United States
- ARQT United States
- Employees
- INOD N/A
- ARQT N/A
- Industry
- INOD EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- INOD Technology
- ARQT Health Care
- Exchange
- INOD Nasdaq
- ARQT Nasdaq
- Market Cap
- INOD 1.2B
- ARQT 1.1B
- IPO Year
- INOD 1993
- ARQT 2020
- Fundamental
- Price
- INOD $36.78
- ARQT $12.68
- Analyst Decision
- INOD Strong Buy
- ARQT Strong Buy
- Analyst Count
- INOD 4
- ARQT 5
- Target Price
- INOD $36.50
- ARQT $17.00
- AVG Volume (30 Days)
- INOD 1.5M
- ARQT 2.1M
- Earning Date
- INOD 02-20-2025
- ARQT 02-25-2025
- Dividend Yield
- INOD N/A
- ARQT N/A
- EPS Growth
- INOD N/A
- ARQT N/A
- EPS
- INOD 0.62
- ARQT N/A
- Revenue
- INOD $137,393,000.00
- ARQT $138,708,000.00
- Revenue This Year
- INOD $93.11
- ARQT $209.03
- Revenue Next Year
- INOD $34.30
- ARQT $49.00
- P/E Ratio
- INOD $59.19
- ARQT N/A
- Revenue Growth
- INOD 71.66
- ARQT 182.84
- 52 Week Low
- INOD $5.46
- ARQT $3.11
- 52 Week High
- INOD $55.17
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- INOD 46.54
- ARQT 43.06
- Support Level
- INOD $32.54
- ARQT $13.10
- Resistance Level
- INOD $46.69
- ARQT $14.36
- Average True Range (ATR)
- INOD 3.01
- ARQT 0.99
- MACD
- INOD -0.70
- ARQT -0.32
- Stochastic Oscillator
- INOD 29.96
- ARQT 1.95
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.